Fusion Antibodies Profit Warning: Shares Down over 30%

fusion antibodies profit warning

The ticker code may read FAB, but the news is anything but for holders in this AIM-listed company. A Fusion Antibodies profit warning has knocked a whopping 30% off the share price. The base case is that it ‘significantly’ reduces profit expectations for FY19, although expectations for the current year remain unchanged. The markets hated … Read more